SPONSOR
Guangdong Provincial People's Hospital
Total Trials
4
Recruiting
4
Phases
Phase 3, Phase 2
Conditions studied: NSCLC (Non-small Cell Lung Cancer)Coronary Heart Disease (CHD)Heart FailureCardiomyopathyCOPDBronchial AsthmaRespiratory FailureThoracic TumorsCardiopulmonary DiseasesNon-Small Cell Lung Cancer
Guangdong Provincial People's Hospital is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including NSCLC (Non-small Cell Lung Cancer), Coronary Heart Disease (CHD), Heart Failure, Cardiomyopathy.
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Guangdong Provincial People's Hospital
How many clinical trials has Guangdong Provincial People's Hospital sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Guangdong Provincial People's Hospital, of which 4 are actively recruiting participants. These trials cover conditions including NSCLC (Non-small Cell Lung Cancer), Coronary Heart Disease (CHD), Heart Failure. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Guangdong Provincial People's Hospital research focus on?
Guangdong Provincial People's Hospital clinical trials span NSCLC (Non-small Cell Lung Cancer), Coronary Heart Disease (CHD), Heart Failure, Cardiomyopathy, COPD, and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Guangdong Provincial People's Hospital clinical trial?
To participate in a Guangdong Provincial People's Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Guangdong Provincial People's Hospital trials with current recruitment status updated daily.
Clinical Trials by Guangdong Provincial People's Hospital
NCT07016126 Phase 3
Recruiting
D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC
NSCLC (Non-small Cell Lung Cancer)
NCT07154355
Recruiting
Community Exercise Treating Effect on Cardiopulmonary Disease Patients
Coronary Heart Disease (CHD)
NCT05800340 Phase 2
Recruiting
Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC
Non-Small Cell Lung Cancer
NCT05841186
Recruiting
Correlation of Timing of Pegfilgrastim Administration and PIBP.
Pegfilgrastim
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology